( 8) has been validated as a reliable cognitive screening test in the older population. The Montreal Cognitive Assessment (MoCA) Test developed by Nasreddine et al.

There is a clear need to develop valid screening tests to ascertain whether cognitive symptoms require further evaluation by neuropsychological testing. The determination of cognitive impairment is based on neuropsychological testing designed to evaluate the main cognitive areas affected by age-related cognitive decline ( 4). The diagnosis of MCI is clinical and is based on Consensus Criteria ( 7). The prevalence of MCI increases with advancing age. Early diagnosis of MCI allows for providing advice regarding the possible benefits of interventions, such as cognitive training ( 5), aerobic exercise ( 6), and planning for the future. While there may be minimal difficulties in instrumental activities of daily living, basic activities of daily living are preserved ( 3, 4). MCI (also termed mild neurocognitive disorder according to DSM 5) ( 2) is a syndrome in which a person experiencing cognitive symptoms is found to have objective cognitive impairment in one or more domains. The transition from normal cognitive aging to mild cognitive impairment (MCI) and subsequent dementia has been well-described ( 1). At a cutoff value of ≥25, sensitivity was 0.99 and specificity 0.54, with area under the curve (AUC) of 0.81.Ĭonclusions: We found the Russian language version of the MoCA test to be a useful cognitive screening instrument for older people with mild cognitive impairment.Īs the population ages, the number of older people with cognitive decline is increasing. The MoCA-Ru score was higher in the AC group than in those with MCI (24.3 ± 3.74 vs. Results: The mean age of the study population was 78 ± 6.6 years and 123 (76.9%) were women. All participants underwent cognitive screening using the Russian version of the MoCA test (MoCA-Ru) as well as evaluation by means of a validated computerized cognitive assessment battery (Neurotrax). Methods: The study population included 160 residents of Israel aged 65 years and older with Russian as their mother tongue, 80 of whom were cognitively asymptomatic (AC) and 80 with a clinical diagnosis of MCI. The aim of the present study was to validate the Russian version of the MoCA test. The MoCA test is a useful cognitive screening instrument, but the Russian version of this test has not yet been validated. Physical exercise and cognitive training may be useful in maintaining cognitive function, and those developing impaired cognitive function should be advised to plan for the future.

5Department of Geriatrics, Soroka Medical Center, Be'er Sheva, Israelīackground: Cognitive impairment is a common condition in older people, and age-related cognitive symptoms may progress to Mild Cognitive Impairment and Dementia.

4Unit for Community Geriatrics, Division of Health in the Community, Ben-Gurion University of the Negev, Be'er Sheva, Israel.

3Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

2Geriatric Unit, Rambam Health Care Campus, Haifa, Israel.

1Department of Family Medicine, Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.

Tamar Freud 1 † Anna Vostrikov 1 † Tzvi Dwolatzky 2,3 Boris Punchik 1,4 Yan Press 1,4,5 *

Test de moca pdf